Neumora Therapeutics (NMRA) Receivables - Other (2022 - 2024)

Neumora Therapeutics (NMRA) posted quarterly Receivables - Other of $1.6 million for Q2 2024, up 80.02% quarter-over-quarter from $906000.0 in Q1 2024.

Neumora Therapeutics (NMRA) Receivables - Other (2022 - 2024) Analysis & Trends

Neumora Therapeutics' Receivables - Other history runs 3 years deep, the most recent figure standing at $1.6 million for Q2 2024.

  • In Q2 2024, Receivables - Other changed N/A year-over-year to $1.6 million; the TTM figure through Jun 2024 stood at $1.6 million (changed N/A YoY), while the FY2023 annual figure was $939000.0, up 2.18% from the prior year.
  • Receivables - Other for Q2 2024 stood at $1.6 million, up from $906000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $1.6 million in Q2 2024, with the low at $668000.0 in Q3 2023.
  • The 3-year median for Receivables - Other is $919000.0 (2022), against an average of $1.0 million.
  • Peak annual rise in Receivables - Other reached 2.18% in 2023, while the deepest fall reached 2.18% in 2023.
  • Neumora Therapeutics' Receivables - Other stood at $919000.0 in 2022, then advanced by 2.18% to $939000.0 in 2023, then surged by 73.7% to $1.6 million in 2024.
  • Business Quant data shows NMRA's Receivables - Other at $1.6 million in Q2 2024, $906000.0 in Q1 2024, and $939000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Neumora Therapeutics 296.45 Mn 296.45 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 1.63 Mn
Jun 30, 2024 1.63 Mn
Mar 31, 2024 906,000.00
Mar 31, 2024 906,000.00
Dec 31, 2023 939,000.00
Dec 31, 2023 939,000.00
Sep 30, 2023 668,000.00
Sep 30, 2023 668,000.00
Dec 31, 2022 919,000.00
Dec 31, 2022 919,000.00